<DOC>
	<DOCNO>NCT02033525</DOCNO>
	<brief_summary>The present proposal objective ass whether addition autologous ex vivo expand mesenchymal stromal cell ( XCEL-M-ALPHA ) conventional meniscal injury rehabilitation program contribute create proper healing environment meniscus repair . For purpose , 20 patient randomize ( 10 per group ) one two treatment arm ( rehabilitation + xcel-m-alpha rehabilitation alone ) . The conduction clinical trial , addition aim improve patient 's quality life , contribute consolidate emerge new type therapy still development .</brief_summary>
	<brief_title>Mesenchymal Stromal Cells Degenerative Meniscus Injury</brief_title>
	<detailed_description>This prospective , unicentric , randomize , open-label , single-dose , two-arm , blind assessor pilot study 20 patient degenerative meniscus injury grade 3 ( Crues et al . ) enter study primary objective assess efficacy treatment VAS pain 12 month . Secondary objective evaluate safety efficacy image procedure clinical questionnaire ( IKDC , KOOS , Lysholm SF-36 . Patients randomize one two treatment arm ( XCEL-M-ALPHA standard rehabilitation program standard rehabilitation program alone ) . Thereafter , patient follow 12 month . Imaging assessment perform independent blinded radiologist .</detailed_description>
	<mesh_term>Wounds Injuries</mesh_term>
	<criteria>Patient 40 60 year age Degenerative meniscus injury grade 3 ( Crues et al . ) Indication conservative treatment Normal alignment knee ( 3ยบ varus 10 ยบ valgus ) Patient able follow rehabilitation program Informed consent give patient write Patient able understand trial . Traumatic meniscus injury Surgical intervention affect knee Local systemic infection Intraarticular treatment affect knee steroid hyaluronic acid within past 3 month Significant abnormal laboratory test contraindicate participation trial . Pregnant woman intend become pregnant breastfeeding Neoplastic process within previous 5 year without complete remission . The patient wear pacemaker , allergy contrast , severe renal insufficiency condition contraindicate magnetic resonance use contrast . Other pathologic condition circumstance difficult participation study accord medical criterion Legally dependant patient . The patient accept followedup period could exceed clinical trial length</criteria>
	<gender>All</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>Chronic Meniscal Injury</keyword>
	<keyword>Degenerative meniscus</keyword>
	<keyword>Meniscus injury</keyword>
	<keyword>Meniscal injury</keyword>
	<keyword>Mesenchymal stromal cell</keyword>
	<keyword>Mesenchymal stem cell</keyword>
	<keyword>Advanced Therapy</keyword>
	<keyword>Bone marrow</keyword>
</DOC>